These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24687212)

  • 1. Reossification of osteolytic metastases at the acetabulum following gefitinib and multidisciplinary treatment for lung cancer: a case report with autopsy findings.
    Kishimoto Y; Iwase T; Yano T; Mori H
    J Orthop Sci; 2015 Sep; 20(5):914-8. PubMed ID: 24687212
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged control of bone metastases in non-small-cell lung cancer patients treated with gefitinib.
    Zampa G; Moscato M; Brannigan BW; Morabito A; Bell DW; Normanno N
    Lung Cancer; 2008 Jun; 60(3):452-4. PubMed ID: 18079016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma.
    Wagner M; Besse B; Balleyguier C; Soria JC
    J Thorac Oncol; 2008 Jun; 3(6):677-9. PubMed ID: 18520813
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal growth factor receptor targeted therapy with gefitinib in locally advanced and metastatic primary lung adenocarcinoma.
    Liam CK; Pang YK; Leow CH
    Respirology; 2006 May; 11(3):287-91. PubMed ID: 16635086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer.
    Yokouchi H; Yamazaki K; Kinoshita I; Konishi J; Asahina H; Sukoh N; Harada M; Akie K; Ogura S; Ishida T; Munakata M; Dosaka-Akita H; Isobe H; Nishimura M
    BMC Cancer; 2007 Mar; 7():51. PubMed ID: 17374153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR exon 19 insertions show good response to gefitinib, but short time to progression in Japanese patients.
    Park J; Kondo C; Shimizu J; Horio Y; Yoshida K; Hida T
    J Thorac Oncol; 2014 Feb; 9(2):e10-1. PubMed ID: 24419426
    [No Abstract]   [Full Text] [Related]  

  • 7. First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer.
    Lange T; Müller-Tidow C; Serve H; Hoffknecht P; Berdel WE; Thomas M
    Oncol Rep; 2005 Dec; 14(6):1539-42. PubMed ID: 16273252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flare phenomenon following gefitinib treatment of lung adenocarcinoma with bone metastasis.
    Hashisako M; Wakamatsu K; Ikegame S; Kumazoe H; Nagata N; Kajiki A
    Tohoku J Exp Med; 2012 Oct; 228(2):163-8. PubMed ID: 23036980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.
    Takeda M; Okamoto I; Tsurutani J; Oiso N; Kawada A; Nakagawa K
    Jpn J Clin Oncol; 2012 Jun; 42(6):528-33. PubMed ID: 22457323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interaction between complementary herbal medicines and gefitinib.
    Hwang SW; Han HS; Lim KY; Han JY
    J Thorac Oncol; 2008 Aug; 3(8):942-3. PubMed ID: 18670318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Muscle metastasis revealing bronchial adenocarcinoma].
    Ketata W; Feki W; Msaad S; Yangui I; Ayoub A
    Rev Mal Respir; 2011 Jan; 28(1):71-4. PubMed ID: 21277477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor (ER) and epidermal growth factor receptor (EGFR) as targets for dual lung cancer therapy: not just a case?
    Giovannini M; Belli C; Villa E; Gregorc V
    J Thorac Oncol; 2008 Jun; 3(6):684-5. PubMed ID: 18520816
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical resection of locally advanced pulmonary adenocarcinoma after gefitinib therapy.
    Liu M; Jiang G; He W; Zhang P; Song N
    Ann Thorac Surg; 2011 Jul; 92(1):e11-2. PubMed ID: 21718818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary bone metastasis as the first clinical manifestation in a patient with small bowel adenocarcinoma.
    Yamada K; Ikehara Y; Nakanishi H; Kozawa E; Tatematsu M; Sugiura H
    J Orthop Sci; 2007 Nov; 12(6):606-10. PubMed ID: 18040646
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.
    Kim JE; Lee DH; Choi Y; Yoon DH; Kim SW; Suh C; Lee JS
    Lung Cancer; 2009 Sep; 65(3):351-4. PubMed ID: 19157632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.
    Katayama T; Shimizu J; Suda K; Onozato R; Fukui T; Ito S; Hatooka S; Sueda T; Hida T; Yatabe Y; Mitsudomi T
    J Thorac Oncol; 2009 Nov; 4(11):1415-9. PubMed ID: 19692934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good response to gefitinib for lung adenocarcinoma with hyperamylasemia: a case report.
    Ko HW; Tsai YH; Yu CT; Huang CY; Chen CH
    Chang Gung Med J; 2008; 31(6):606-11. PubMed ID: 19241901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sternal mass presenting as a first manifestation of lung cancer.
    Marcos PJ; Rodríguez-Lorenzo A
    Am J Med Sci; 2013 Nov; 346(5):420. PubMed ID: 24157964
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of bevacizumab for bone scintigraphy imaging: A case report.
    Asano T; Takakuwa O; Maeno K; Oguri T; Niimi A
    J Cancer Res Ther; 2015; 11(3):652. PubMed ID: 26458633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
    Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
    Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.